St. Mary's of Michigan - Saginaw St. Mary's of Michigan - Standish St. Joseph Health System - Tawas  
  St. Mary's of Michigan   Believe in Better
Home  |   Contact  |   Careers  |   Associates  |   Physicians
 I Want To...

Printed for you from the St. Mary's of Michigan website on 07/30/16
News Archive
  Find A Location
  Find A Doctor

click to Google Map™ to this location
800 S. Washington Ave.
Saginaw, MI 48601
(click map for directions)

font:small fontmed fontlarge font |
News Release Date : 11/19/2010

New Lung Cancer Study

STARS Protocol - International randomized phase III study to compare CyberKnife Stereotactic Radiotherapy with Surgical Resection in stage I non-small cell lung cancer.
Lung cancer remains the most frequent cause of cancer death in both men and women in the world. Surgical resection using lobectomy with mediastinal lymph node dissection or sampling has been the standard of care for operable early stage non-small cell lung cancer (NSCLC). Several studies have reported high local control and survival using Stereotactic Body RadioTherapy (SBRT) in stage I NSCLC patients. SBRT is now an acceptable treatment for medically inoperable patients with stage I NSCLC and patients with operable stage I lung cancer that are entered on clinical protocols.
The purpose of this study is to conduct a phase III randomized study to compare CyberKnife SBRT with surgery, the current standard of care for stage I operable NSCLC.
The sponsor for this study is Accuray Incorporated in collaboration with M.D. Anderson Cancer Center. If you know of someone who may be interested in the study, please call St. Mary's of Michigan's research staff at 907-8411 for further information.

800 South Washington Avenue | Saginaw, MI 48601 |
(989) 907-8000 | 1-844-907-8000
` © 2016 AHIS / St. Mary's of Michigan